Page last updated: 2024-08-24

epigallocatechin gallate and Atheroma

epigallocatechin gallate has been researched along with Atheroma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, B; Li, Y; Shi, H; Wang, F; Wang, H; Wang, L; Wang, Q; Wang, Z; Yang, Z; Zhang, J	1
Cao, Y; Shan, Z; Teng, W; Wang, D; Wang, X; Zhang, J	1

Other Studies

2 other study(ies) available for epigallocatechin gallate and Atheroma

Article	Year
Green tea polyphenol epigallocatechin-3-gallate increases atherosclerotic plaque stability in apolipoprotein E-deficient mice fed a high-fat diet. Kardiologia polska, 2018, Volume: 76, Issue:8 Topics: Animals; Apolipoproteins E; Basigin; Catechin; Cytokines; Diet, High-Fat; Gene Expression Regulation; Inflammation; Macrophages; Male; Matrix Metalloproteinases; Mice; Mice, Transgenic; Myocytes, Smooth Muscle; Plaque, Atherosclerotic; Tea	2018
(-)-Epigallocatechin gallate inhibits TNF-α-induced PAI-1 production in vascular endothelial cells. Journal of cardiovascular pharmacology, 2013, Volume: 62, Issue:5 Topics: Catechin; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Flavonoids; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Phosphorylation; Plaque, Atherosclerotic; Plasminogen Activator Inhibitor 1; Receptors, Tumor Necrosis Factor, Type I; Tea; Time Factors; Tumor Necrosis Factor-alpha	2013

Article

Year

Green tea polyphenol epigallocatechin-3-gallate increases atherosclerotic plaque stability in apolipoprotein E-deficient mice fed a high-fat diet.

Kardiologia polska, 2018, Volume: 76, Issue:8

Topics: Animals; Apolipoproteins E; Basigin; Catechin; Cytokines; Diet, High-Fat; Gene Expression Regulation; Inflammation; Macrophages; Male; Matrix Metalloproteinases; Mice; Mice, Transgenic; Myocytes, Smooth Muscle; Plaque, Atherosclerotic; Tea

2018

(-)-Epigallocatechin gallate inhibits TNF-α-induced PAI-1 production in vascular endothelial cells.

Journal of cardiovascular pharmacology, 2013, Volume: 62, Issue:5

Topics: Catechin; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Flavonoids; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Phosphorylation; Plaque, Atherosclerotic; Plasminogen Activator Inhibitor 1; Receptors, Tumor Necrosis Factor, Type I; Tea; Time Factors; Tumor Necrosis Factor-alpha

2013